Gilead to buy CymaBay for $4.3 billion in bets on liver disease…
By Bhanvi Satija (Reuters) -Gilead Sciences has agreed to buy CymaBay Therapeutics for…
N2:BIODRG
Pfizer posts surprise 4th quarter profit, but key products miss on…
By Michael Erman and Bhanvi Satija (Reuters) -Pfizer reported a surprise quarterly profit…
Pfizer looks beyond COVID after quarterly loss on Paxlovid charge
By Bhanvi Satija and Michael Erman (Reuters) - Pfizer on Tuesday urged investors to focus…
New COVID shots still hard to find for some Americans
By Michael Erman and Ahmed Aboulenein NEW YORK/WASHINGTON (Reuters) - Americans have…
About 4 million Americans got updated COVID vaccines in September
By Ahmed Aboulenein and Michael Erman (Reuters) -Around 4 million Americans received the…
US govt awards $1.4 billion for development of new COVID therapies,…
(Reuters) - The U.S. government said on Tuesday it had awarded $1.4 billion for the…